In the News

How to Get a Special Dividend at Barron’s
The Security I like Best (PDF) by Warren Buffett
College is a scam at MarketWatch
Is Farmland A Smart Hedge Against Inflation?  at Gonzalo Lira
Fidelity and Putnam Among Fund Families Duped by Longtop at Morningstar
The U.S. Postal Service Nears Collapse at BusinessWeek
Prospects Climb at Ryanair at Barron’s
Hedge-fund secrets to beat the market at MarketWatch
Jim Cramer Calls LinkedIn IPO Action A Sham at MarketWatch
The Invisible Stock Bubble at SmartMoney
Will Illumina Find New Life At 50-Day Line? at Investor’s Business Daily
As Lenders Hold Homes in Foreclosure, Sales Are Hurt at NYT
Fleckenstein Doesn't See Technology Industry `Bubble' (Video) at Bloomberg
Facing Up to End of 'Easy Oil' at WSJ
Clearing Firm Rattles Investors at Barron’s
Tag, You're It! Too Big to Fail Risk Transferred, Not Eliminated at The Atlantic
Next Danger: "Splash Crash" at Barron’s
Death Derivatives: Wall Street’s Latest Ill-Advised Maneuver at Minyanville
Biggs Buying as S&P 500 Profit Forecasts Rise Most in a Year at Bloomberg
Berkley Forms New London Unit at Zacks
May Not Be Bearish Enough on China Real Estate: Chanos at Bloomberg
Hartford Sells Unit to CenterState at Zacks
The Dow at 115: Its Close Relationship to GDP at WSJ
Dow Theory: Still Sending a Bullish Signal? at WSJ
Target Says ‘Limited Number’ of Buyers for Card Portfolio at Bloomberg
Farmers Will Do Well at SeekingAlpha

Watch List Notes

It was reported on May 24, 2011 that Carl Icahn sold a large portion of his Biogen Idec (BIIB).  This pretty much closes the initiation of Mr. Icahn’s position in Biogen Idec (BIIB) which was started back in June 2007.  The average compounded annual gain for Mr. Icahn over the four-year period was slightly above 20%.  However, based on Biogen Idec (BIIB) being on our Watch List of October ,with our sell recommendation of Biogen Idec (BIIB) on April 21, 2011, the compounded annualized gain was 77%.
Carl Icahn Buys Biogen Idec at GuruFocus June 2007

Carl Icahn Sells 2.6 Million Shares in Biogen as Other Execs Sell at Barron’s May 2011
October 2009 Nasdaq List at NLO
April 2011 Sell BIIB/Buy TEVA at NLO

Please consider donating to the New Low Observer. Thank you.

Comments are closed.